INR Innovative Properties Inc.

Nabis Holdings Announces Private Placement of Up to C$30 Million of Debenture Units

Nabis Holdings Announces Private Placement of Up to C$30 Million of Debenture Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Innovative Properties Inc. d/b/a Nabis Holdings (CSE:NAB; OTC: INNPF, FRA:7IP) (“Nabis” or the “Company”) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and Eventus Capital Corp. to act as co-lead agents and co-bookrunners, on behalf of a syndicate of agents (collectively, the “Agents”), with respect to a commercially reasonable efforts brokered private placement of debenture units (“Debenture Units”) for aggregate gross proceeds to Nabis of up to C$30,000,000 (the “Offering”), each Debenture Unit being comprised of C$1,000 in principal amount of unsecured convertible debentures of Nabis (the “Convertible Debentures”) and 1,111 common share purchase warrants of Nabis (the “Warrants”). Each Warrant shall be exercisable to acquire one common share of Nabis (“Nabis Share”) at an exercise price of C$1.50 per share for a period of 36 months from the date of closing of the Offering (the “Closing Date”), regardless of whether the Convertible Debentures are converted.  The Agents shall have the option, exercisable at any time up until 48 hours prior to the Closing Date to arrange for the sale of additional Debenture Units for additional aggregate gross proceeds to Nabis of up to C$5,000,000.

The Convertible Debentures will mature 36 months from the Closing Date, will bear interest at a rate equal to 8% per annum, payable on the last day of each calendar quarter, and will be convertible at the option of the holder into Nabis Shares at a price of C$0.90 per Nabis Share (the “Conversion Price”).

The Convertible Debentures will be subject to early redemption, in whole or in part, by the Company at any time after the first anniversary of the Closing Date at a price equal to the then outstanding principal amount of the Convertible Debentures plus all accrued and unpaid interest thereon up to and including the redemption date.

Commencing on the date that is four months and one day following the Closing Date, the Company may convert the Convertible Debentures into Nabis Shares at the Conversion Price if the daily volume weighted average trading price of the Nabis Shares is greater than C$1.65 for the preceding 10 consecutive trading days. Holders having their Convertible Debentures converted will receive accrued and unpaid interest thereon in cash.

The net proceeds of the Offering will be used to fund cannabis related investments, for strategic investment opportunities and for general working capital purposes.

As consideration for their services provided in connection with the Offering, the Company has agreed to: (i) pay the Agents a cash commission equal to 6% of the gross proceeds of the Offering, and (ii) issue the Agents such number of warrants (the “Agents’ Warrants”) equal to 6.0% of the of the gross proceeds Offering divided by the Conversion Price.  Each Agents’ Warrant will be exercisable by the holder at an exercise price equal to the Conversion Price and at any time prior to the date that is 36 months following the Closing Date to acquire one unit consisting of one Nabis Share and one Warrant.

The Convertible Debentures, Warrants and Agents’ Warrants, as well as the underlying Nabis Shares, will be subject to a resale restrictions for a period of four months from the Closing Date.

The Closing Date is expected to occur on or about February 28th, 2019. The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Canadian Securities Exchange.

The securities described herein have not been registered under the U.S. Securities Act of 1933, as amended (the “Act”), and may not be offered or sold in the United States unless registered under the Act or unless an exemption from registration is available.

About Innovative Properties Inc. (d/b/a Nabis Holdings)

Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical (CSE:MPX), one of the largest takeovers in the U.S. Cannabis space to date, the company has proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on  revenue generation, EBITDA and growth.

ON BEHALF OF THE BOARD OF DIRECTORS

“Shay Shnet”

Shay Shnet

CEO and Director

For inquiries, please contact 604-687-7130 or email .

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the Offering will be completed by the Company or completed upon the terms disclosed; the Canadian Securities Exchange will approve the Offering; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

EN
30/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Innovative Properties Inc.

 PRESS RELEASE

Nabis Holdings Commences Trading on the OTCQB® Venture Market in the ...

Nabis Holdings Commences Trading on the OTCQB® Venture Market in the U.S. Nabis Changes Fiscal Year-End to December 31 VANCOUVER, British Columbia, Nov. 13, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTCQB: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that its common stock has been approved for trading on the OTCQB® Venture Market under the ticker symbol “NABIF,” effective as of the opening of trading today, November 13, 2019. The Company will continu...

 PRESS RELEASE

Nabis Holdings Closes Acquisition of Emerald Phoenix and Infusion Edib...

Nabis Holdings Closes Acquisition of Emerald Phoenix and Infusion Edibles in Arizona Closing of acquisition is non-dilutive as no Nabis common shares are issued VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has completed the acquisition of 100% of the membership units of Perpetual Healthcare Inc. This acquisition, previously announced on August 12, 2019 and Oc...

 PRESS RELEASE

Nabis Holdings Receives Regulatory Approval to Operate its New Assets,...

Nabis Holdings Receives Regulatory Approval to Operate its New Assets, Emerald Phoenix and Infusion Edibles in Arizona VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has received all required regulatory approvals to operate the assets of Perpetual Healthcare Inc, Emerald Phoenix, a licensed medical marijuana dispensary located in Phoenix, Arizona and Infusion Edi...

 PRESS RELEASE

Nabis Holdings Appoints Richard Dolan as Vice President of Investor Re...

Nabis Holdings Appoints Richard Dolan as Vice President of Investor Relations VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has appointed as Vice President of Investor Relations. Mr. Dolan joins Nabis bringing 27 years of experience within the wealth management realm. From building significant books of business personally to playing various and vital roles wi...

 PRESS RELEASE

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2...

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2019 Financial Results Strengthened management team with the appointment of Nicole Rusaw as Chief Financial Officer Cash and cash equivalents of CAD$20.3 million as of July 31, 2019 VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, reported its financial results for the third quarter ended July 31, 2019. All financial i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch